St. Charles Medical Center – Bend is a hospital in Bend, Oregon, United States. It is the largest hospital in Central Oregon, and a level 2 trauma center. St. Charles medical center [SCMC-B] is owned and operated by St. Charles Health System, Inc., a private, not-for-profit Oregon corporation.

There are 226 beds in Saint Charles Medical Center-Bend.

During the past decade, Saint Charles Medical Center-Bend conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Charles Medical Center-Bend" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Saint Charles Medical Center-Bend" are "Adenocarcinoma of the Rectum" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials), "Kidney Cancer" (1 trials), "Progesterone Receptor Positive Tumor" (1 trials) and "Prostate Adenocarcinoma" (1 trials). Many other conditions were trialed in "Saint Charles Medical Center-Bend" in a lesser frequency.

Most popular intervention types in "Saint Charles Medical Center-Bend" are "Drug" (5 trials), "Other" (4 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "Bevacizumab" (1 trials), "Bicalutamide" (1 trials), "Carboplatin" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Charles Medical Center-Bend" are 3 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Charles Medical Center-Bend". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Saint Charles Medical Center-Bend, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Charles Medical Center-Bend, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".